Chemed Quarterly Cash Flow Statement
NYSE: CHEHealth CareMedical/Nursing ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Chemed free cash flow
In the quarter ended Jun 30, 2026, Chemed generated $84.8 million of operating cash flow and spent $15.5 million on capital expenditures. That left free cash flow of $69.3 million, a free-cash-flow margin of 10.3% of revenue. Free cash flow was down 43.6% from the prior year's $122.8 million.
Chemed returned $105.4 million to shareholders: $7.9 million in dividends and $97.5 million in share repurchases, equal to 152% of free cash flow. Free cash flow covered dividend payments 8.8 times.
Summary generated from market data by MetaCap's automated system. Methodology
Chemed cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 67.70M | 66.30M | 76.75M | 64.24M | 52.49M | 71.76M | 90.32M | 75.78M | 70.89M | 65.02M | 90.05M | 74.96M |
| Net Income growth (YoY) | +28.98% | -7.60% | -15.02% | -15.23% | -25.95% | +10.37% | +0.30% | +1.09% | +32.80% | +20.13% | +44.95% | +31.80% |
| Depreciation & Amortization | 16.99M | 16.87M | 16.33M | 16.23M | 16.26M | 16.02M | 15.83M | 15.70M | 15.71M | 15.81M | 15.54M | 15.38M |
| Change in Working Capital | 31.30M | -27.22M | 17.06M | -9.02M | 108.70M | -85.63M | 36.99M | -14.34M | 15.01M | -35.28M | -6.63M | -73.88M |
| Operating Cash Flow | 84.81M | 88.22M | 133.53M | 83.39M | 138.61M | 32.74M | 164.91M | 90.52M | 77.52M | 84.55M | 108.56M | 28.93M |
| Capital Expenditures | -15.52M | -17.12M | -16.35M | -17.36M | -15.81M | -13.28M | -12.76M | -13.54M | -11.06M | -12.16M | -11.78M | -11.65M |
| Investing Cash Flow | -28.24M | -37.79M | -15.95M | -14.23M | -15.48M | -13.67M | -12.52M | -18.52M | -93.49M | -19.39M | -11.67M | -15.44M |
| Dividends Paid | -7.88M | -8.17M | -8.50M | -8.65M | -7.22M | -7.33M | -7.50M | -7.49M | -6.06M | -6.05M | -6.06M | -6.03M |
| Share Repurchases | -97.48M | -190.04M | -174.56M | -180.78M | -42.95M | -33.22M | -209.34M | -57.82M | -55.77M | -38.46M | -39.93M | -14.34M |
| Financing Cash Flow | -33.21M | -108.09M | -172.82M | -189.31M | -47.10M | -23.54M | -212.49M | -56.45M | -74.47M | -15.77M | -6.08M | -263.00K |
| Net Change in Cash | 23.37M | -57.66M | -55.24M | -120.15M | 76.02M | -4.47M | -60.10M | 15.55M | -90.45M | 49.39M | 90.81M | 13.23M |
| Free Cash Flow | 69.29M | 71.10M | 117.19M | 66.03M | 122.80M | 19.46M | 152.15M | 76.97M | 66.45M | 72.39M | 96.78M | 17.27M |
This table shows 12 quarterly periods of Chemed's cash flow statement, from Q2 2026 back to Q3 2023, across 13 line items including net income, depreciation & amortization, change in working capital. Values in USD; B = billions, M = millions. Fiscal periods follow CHE's reporting calendar. What is a cash flow statement?